Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0029463 (
osteosarcoma
)
16,637
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Nitidine
chloride (NC) has been demonstrated to exert a tumor-suppressive function in various types of human cancers. However, the detailed mechanism of NC-mediated anti-tumor effects remains elusive. It has been reported that SIN1, a component of mTORC2 (mammalian target of rapamycin complex C2), plays an oncogenic role in a variety of human cancers. Therefore, the inhibition of SIN1 could be useful for the treatment of human cancers. In this study, we explored whether NC triggered an anti-cancer function via the inhibition of SIN1 in
osteosarcoma
(OS) cells. An MTT assay was performed to measure the effect of NC on the cell growth of
osteosarcoma
cells, and flow cytometry was used to detect the apoptotic rate of the cells after NC treatment. The expression of SIN1 was detected by western blotting. Wound-healing assay and Transwell chamber invasion assay were conducted to analyze the motility of
osteosarcoma
cells following NC exposure. We found that exposure to NC led to the inhibition of cell growth, migration, and invasion and the induction of apoptosis. Mechanistically, we found that NC inhibited the expression of SIN1 in
osteosarcoma
cells. Overexpression of SIN1 abrogated the inhibition of cell growth and motility induced by NC in
osteosarcoma
cells. Our results indicate that NC exhibits its tumor-suppressive activity via the inhibition of SIN1 in
osteosarcoma
cells, suggesting that NC could be a potential inhibitor of SIN1 in
osteosarcoma
.
...
PMID:Nitidine Chloride Inhibits SIN1 Expression in Osteosarcoma Cells. 3084 86